Diane Simeone will join the NYU Langone Medical Center’s Perlmutter Cancer Center March 1 to serve as associate director for translational research and to lead its newly established pancreatic cancer center. Simeone is the director of the gastrointestinal oncology program at University of Michigan Comprehensive Cancer Center.
Her laboratory was the first to identify pancreatic cancer stem cells, a discovery that might explain why current drug therapies are ineffective against the disease. She also leads a research program on pancreatic cancer prevention, early detection and therapeutics, and holds major leadership positions with organizations advancing pancreatic cancer research and advocacy worldwide.
